WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Ver el documentoIntroduction
Abrir esta carpeta y ver su contenidoParasitic infections
Abrir esta carpeta y ver su contenidoInsect and arachnid bites and stings
Abrir esta carpeta y ver su contenidoSuperficial fungal infections
Abrir esta carpeta y ver su contenidoSubcutaneous fungal infections
Abrir esta carpeta y ver su contenidoBacterial infections
Abrir esta carpeta y ver su contenidoViral infections
Abrir esta carpeta y ver su contenidoEczematous diseases
Abrir esta carpeta y ver su contenidoScaling diseases
Abrir esta carpeta y ver su contenidoPapulosquamous diseases
Ver el documentoCutaneous reactions to drugs
Abrir esta carpeta y ver su contenidoPigmentary disorders
Abrir esta carpeta y ver su contenidoPremalignant lesions and malignant tumours
Abrir esta carpeta y ver su contenidoPhotodermatoses
Abrir esta carpeta y ver su contenidoBullous dermatoses
Ver el documentoAlopecia areata
Ver el documentoUrticaria
Abrir esta carpeta y ver su contenidoConditions common in children
Ver el documentoAcne vulgaris
Ver el documentoPruritus
Ver el documentoTropical ulcers
Abrir esta carpeta y ver su contenidoAntimicrobial drugs
Abrir esta carpeta y ver su contenidoAntifugal drugs
Abrir esta carpeta y ver su contenidoAntiseptic agents
Abrir esta carpeta y ver su contenidoKeratoplastic and keratolytic agents
Abrir esta carpeta y ver su contenidoScabicides and pediculicides
Abrir esta carpeta y ver su contenidoAnti-inflammatory and antipruritic drugs1
Abrir esta carpeta y ver su contenidoAntiallergics and drugs used in anaphylaxis
Abrir esta carpeta y ver su contenidoUltraviolet radiation-blocking agents (sunscreens)
Cerrar esta carpetaMiscellaneous drugs
Ver el documentoDapsone
Ver el documentoFluorouracil
Ver el documentoMethoxsalen
Ver el documentoPodophyllum resin
Abrir esta carpeta y ver su contenidoAnnex
Ver el documentoSelected WHO Publications of Related Interest
Ver el documentoBack cover
 

Podophyllum resin

Solution, 10-25%

General information

Podophyllum resin is a powdered mixture of resins extracted from the roots of Podophyllum pelltatum. A solution is prepared by forming a paste with benzoin in alcohol. It is a caustic keratolytic agent for topical application.

Clinical information

Uses

Topical treatment of genital warts (condylomata acuminata).

Dosage and administration

Adults and children: a 10-25% solution should be applied to the affected area. Care must be taken to avoid contact with normal tissue. Zinc oxide paste may be used to protect the surrounding skin. The residue on the skin should be thoroughly rinsed off after 1-4 hours.

Treatment may be repeated at weekly intervals up to a maximum of four applications.

The active ingredient podophyllotoxin (0.5%) is available in some countries. It is less corrosive and can be applied without medical supervision.

Contraindications

Podophyllum resin should not be applied to large areas of skin, nor should it be used in the treatment of cervical, urethral, anorectal or oral warts.

Treatment is contraindicated during pregnancy since podophyllum resin is both teratogenic and fetotoxic.

Precautions

Preparations of podophyllum resin should be used only under close medical supervision because potentially serious local and systemic toxic effects can result from prolonged or excessive applications. Systemic absorption is enhanced when applications are made to friable, bleeding warts.

Adverse effects

The systemic effects of excessive cutaneous absorption include nausea, vomiting, abdominal pain and diarrhoea.

Transient leukopenia and thrombocytopenia sometimes occur, providing evidence of bone-marrow depression.

Gross over-application can result in serious neurotoxicity. The signs are characteristically delayed in onset and slow to resolve. They include visual and auditory hallucinations, delusions, disorientation, confusion and delirium.

Storage

Topical solution should be kept in tightly closed containers, protected from light and excessive heat. The shelf-life of the resin is highly variable and some formulations may begin to degrade within a few days of exposure to light, air or heat.

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 24 abril 2012